Medications

Pfizer, Allergan to merge in $160 bn tax-saving deal (Update 3)

US-based Pfizer announced Monday a $160 billion merger with Ireland-based Allergan to create the world's biggest pharmaceutical group and shift to a lower-tax jurisdiction despite government policies discouraging such deals.

Medications

FDA warns of bogus botox

(HealthDay)—Counterfeit Botox may have been distributed to doctors' offices and medical clinics across the United States, the U.S. Food and Drug Administration warns.

Other

FDA approves new silicone breast implants

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

Diseases, Conditions, Syndromes

Sling offers lasting benefit for stress urinary incontinence

(HealthDay)—Stress urinary incontinence treatment with a distal urethral polypropylene sling procedure is associated with excellent long-term efficacy and durability, according to research published in the November issue ...

Overweight & Obesity

Weight loss linked to reduced cancer incidence, mortality

(HealthDay) -- Weight loss, particularly intentional weight loss, is associated with a reduced incidence of cancer and mortality, especially for women and for obesity-related cancers, according to a review published online ...

Medications

Botox developer rues missing out on billions

Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.

Medications

US approves Botox for bladder control

The face-freezing pharmaceutical injection Botox gained another medical use on Wednesday when the US government approved it for use in some patients with overactive bladder.

Other

AbbVie makes $63B bid for Botox maker Allergan

Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth.

page 1 from 5

Allergan

Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products.

This text uses material from Wikipedia, licensed under CC BY-SA